Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

• C. J. Fisher

収録刊行物

• JAMA: The Journal of the American Medical Association

  JAMA: The Journal of the American Medical Association 271 (23), 1836-1843, 1994-06-15

  American Medical Association (AMA)

キーワード

• General Medicine

詳細情報

• CRID: 1361981469806066432
• NII論文ID: 30005355689
• NII書誌ID: AA00692850
• DOI: 10.1001/jama.271.23.1836
• ISSN: 15383598
• ISSN: 00987484
• データソース種別:
  • Crossref
  • CiNii Articles